Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Lars Olof Larsson"'
Autor:
Giovanni Ferrara, Davide Valentini, Martin Rao, Jan Wahlström, Johan Grunewald, Lars-Olof Larsson, Susanna Brighenti, Ernest Dodoo, Alimuddin Zumla, Markus Maeurer
Publikováno v:
International Journal of Infectious Diseases, Vol 56, Iss C, Pp 167-175 (2017)
Introduction: Sarcoidosis is considered an idiopathic granulomatous disease, although similar immunological and clinical features with tuberculosis (TB) suggest mycobacterial involvement in its pathogenesis. High-content peptide microarrays (HCPM) ma
Externí odkaz:
https://doaj.org/article/fa92314918664b3d86294f2a9f0fd027
Autor:
Lars Olof Larsson
Publikováno v:
Baltic Journal of Art History. 20:81-107
The paper discusses a set of etchings depicting different buildingsin Gdansk (Danzig) and different parts of the city, first publishedin 1617. The artist was the little known Ægidius Dickman, active inGdánsk and probably also in the Netherlands in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6beee80d75f1d5b5b9c2be2759553768
https://doi.org/10.12697/bjah.2020.20.03
https://doi.org/10.12697/bjah.2020.20.03
Autor:
Platon I Eliseev, Andrey O Maryandyshev, Elena I Nikishova, Irina V Tarasova, Galina P Gorina, Erja Chryssanthou, Malin Ridell, Lars-Olof Larsson
Publikováno v:
International Journal of Mycobacteriology, Vol 2, Iss 2, Pp 103-108 (2013)
Background: Tuberculosis (TB) is a major problem in Russia, particularly regarding multidrug-resistant tuberculosis (MDR-TB). Rapid drug susceptibility testing methods are therefore needed. Objectives: To perform epidemiological analyses of TB in the
Externí odkaz:
https://doaj.org/article/cc02e26a078e4949b6487991450362c2
Autor:
Lars-Olof Larsson
Publikováno v:
International Journal of Mycobacteriology, Vol 5, Iss 5, Pp 29-30 (2016)
A major change of therapy in respiratory medicine has been the transition from oral or parenteral to inhalation therapy, for example, in asthma. Inhalation of anti-infectious drugs has however not a key-role in the treatment of pulmonary infections s
Externí odkaz:
https://doaj.org/article/90e24f83c84442cc9c7e39e719f0ed7e
Publikováno v:
International Journal of Mycobacteriology, Vol 4, Iss 5, Pp 172-173 (2015)
Aim and objectives: To implement a collaborative tuberculosis (TB) project involving a low- and a high-endemic country for improved prevention and treatment of TB in both countries. Methods: Descriptive analyses in Somaliland and in Sweden based on t
Externí odkaz:
https://doaj.org/article/312d9621f9394436816d281591c08376
Publikováno v:
International Journal of Mycobacteriology, Vol 4, Iss 5, Pp 72-73 (2015)
Aim and objectives: To evaluate the implementation of an outpatient TB-clinic in a low-endemic setting. Background: In May 2014 the World Health Organization (WHO) approved the post-2015 global tuberculosis (TB) strategy including the plan for elimin
Externí odkaz:
https://doaj.org/article/73aeb23d81744c80b6b20ce5530fd91d
The number of patients infected with nontuberculous mycobacteria (NTM) is increasing and presents severe health problems. NTM infections in children are not uncommon and differ in several aspects from NTM infections in adults. In children, lymph node
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1bc9718fdf9f88e62de0ef95308401d2
https://doi.org/10.1016/b978-0-12-814692-7.00005-x
https://doi.org/10.1016/b978-0-12-814692-7.00005-x
Autor:
Niek Dekker, Fabrizio Giordanetto, Laurent Knerr, Lars-Olof Larsson, Nidhal Selmi, Jenny Sandmark, Ulla Karlsson, Eva Hurt-Camejo, Peter Nordberg, Marie Castaldo, Mikael Dahlström, Birgitta Rosengren, Ingemar Starke, Daniel Pettersen
Publikováno v:
ACS Medicinal Chemistry Letters. 7:884-889
Expedited structure-based optimization of the initial fragment hit 1 led to the design of (R)-7 (AZD2716) a novel, potent secreted phospholipase A2 (sPLA2) inhibitor with excellent preclinical pharmacokinetic properties across species, clear in vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc1bd66b430756a7150d5201c276dbbd
https://doi.org/10.1021/acsmedchemlett.6b00188
https://doi.org/10.1021/acsmedchemlett.6b00188
Autor:
Lars Olof Larsson
Publikováno v:
Queen Hedwig Eleonora and the Arts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a41ee59a4921775e320575834d5857a3
https://doi.org/10.4324/9781315089249-8
https://doi.org/10.4324/9781315089249-8
Autor:
Wouter Hoefsloot, Luigi Codecasa, Roland Diel, Stephen G. Jenkins, Lars-Olof Larsson, Eva Polverino, Michael R. Loebinger
Publikováno v:
Expert Review of Respiratory Medicine, 11, 12, pp. 977-989
Expert Review of Respiratory Medicine, 11, 977-989
Expert Review of Respiratory Medicine, 11, 977-989
Item does not contain fulltext INTRODUCTION: The number of patients with pulmonary disease caused by non-tuberculous mycobacteria (NTM) is increasing globally. Poor resistance against infections, for example, due to pre-existing lung diseases, immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d69a59814476962c06be1486ecd0766
https://hdl.handle.net/2066/181788
https://hdl.handle.net/2066/181788